Age-related Macular Degeneration

Showing NaN - NaN of 13

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age-Related Macular Degeneration Trial in United States (Iptacopan (LNP023), Placebo)

Recruiting
  • Age-Related Macular Degeneration
  • Iptacopan (LNP023)
  • Placebo
  • Sacramento, California
  • +9 more
Sep 20, 2022

Progression of Intermediate Age-Related Macular Degeneration

Recruiting
  • Age-Related Macular Degeneration
  • No intervention
  • Encino, California
  • +4 more
Aug 8, 2022

Age-Related Macular Degeneration Trial in Philippines, United States (2.0 mg DE-122 Injectable Solution + Lucentis, 4.0 mg

Completed
  • Age-Related Macular Degeneration
  • 2.0 mg DE-122 Injectable Solution + Lucentis
  • +2 more
  • Gilbert, Arizona
  • +13 more
Jun 22, 2021

Age-Related Macular Degeneration Trial in Worldwide (SB11 (Proposed ranibizumab biosimilar), Lucentis (ranibizumab))

Completed
  • Age-Related Macular Degeneration
  • SB11 (Proposed ranibizumab biosimilar)
  • Lucentis (ranibizumab)
  • Poway, California
  • +74 more
Apr 29, 2021

Choroidal Neovascularization, Age-related Macular Degeneration Trial in United States (hI-con1, ranibizumab, Sham injection)

Completed
  • Choroidal Neovascularization
  • Age-related Macular Degeneration
  • hI-con1
  • +2 more
  • Phoenix, Arizona
  • +47 more
Sep 23, 2020

Age-Related Macular Degeneration Trial in United States (0.5 mg of DE-122, 1.0 mg of DE-122, 2.0 mg of DE-122)

Completed
  • Age-Related Macular Degeneration
  • 0.5 mg of DE-122
  • +3 more
  • Mountain View, California
  • +4 more
Jan 10, 2020

Retinal Drusen, Age-related Macular Degeneration, Macular Degeneration Trial in Austin (Lumega-Z, AREDS2)

Completed
  • Retinal Drusen
  • +2 more
  • Lumega-Z
  • AREDS2
  • Austin, Texas
    Eye Clinic of Austin
May 9, 2019

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
  • Age-Related Macular Degeneration
  • Tucson, Arizona
  • +120 more
Aug 13, 2018

Age-Related Macular Degeneration Trial in Worldwide (E10030, ranibizumab, E10030 sham intravitreal injection)

Terminated
  • Age-Related Macular Degeneration
  • Phoenix, Arizona
  • +114 more
Aug 8, 2018

Age-Related Macular Degeneration Trial in United States (HuCNS-SC sub-retinal transplantation)

Terminated
  • Age-Related Macular Degeneration
  • HuCNS-SC sub-retinal transplantation
  • Tucson, Arizona
  • +11 more
May 31, 2016

Seven Year Update of Macular Degeneration Patients

Completed
  • Age-related Macular Degeneration
    • Beverly Hills, California
    • +11 more
    Nov 12, 2013

    Age-related Macular Degeneration Trial in United States (Ranibizumab)

    Completed
    • Age-related Macular Degeneration
    • Phoenix, Arizona
    • +98 more
    Dec 11, 2012

    Macular Degeneration, Age-related Macular Degeneration Trial in Fargo, Austin (Pazopanib eye drops and Allergen Refresh Plus eye

    Completed
    • Macular Degeneration
    • Age-related Macular Degeneration
    • Pazopanib eye drops and Allergen Refresh Plus eye drops
    • Fargo, North Dakota
    • +1 more
    Mar 15, 2012